title: [OPTIMAL APPROACH TO COMBINED TREATMENT OF PATIENTS WITH UROGENITAL PAPILLOMATOSIS].
abstract: The review analyzed 59 sources of domestic and foreign literature on the use of immunomodulator izoprinozin in treating patients infected with human papilloma virus, and the results of their own experience. The high prevalence of HPV and its role in the development of cervical cancer are shown, the mechanisms of HPV development and the host protection from this infection are described. The authors present approaches to the treatment of HPV-infected patients with particular attention to izoprinozin. Isoprinosine belongs to immunomodulators with antiviral activity. It inhibits the replication of viral DNA and RNA by binding to cell ribosomes and changing their stereochemical structure. HPV infection, especially in the early stages, may be successfully cured till the complete elimination of the virus. Inosine Pranobex (izoprinozin) having dual action and the most abundant evidence base, may be recognized as the optimal treatment option.
authors: A A
authors: AA
authors: Breusov
authors: E V
authors: EV
authors: Kulchavenya
authors: E V
authors: EV
authors: Brizhatyukl
authors: P N
authors: PN
authors: Filimonov
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003218:Condylomata Acuminata / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D007542:Inosine Pranobex / Q000627:therapeutic use*; D027383:Papillomaviridae
chemical_list: D000998:Antiviral Agents; D007542:Inosine Pranobex